PureTech Health PLC R&D Day Transcript
Good morning. I'm Allison Mead Talbot, Head of Communication at PureTech, and I'd like to thank you all for joining us for PureTech's inaugural R&D Day. This first one is virtual, but we look forward to hosting you all in person next time.
During today's event, you will hear from leading experts as they share their clinical perspectives and insights into therapeutic opportunities and lymphatic disorders, fibrotic and inflammatory conditions and immuno-oncology. PureTech team members will also take a deep dive into our Wholly Owned Pipeline, in addition to discussing new and important drivers of our future growth. We will have a Q&A session following each key opinion leader presentation, and PureTech's management team will take questions at the end of the event. (Operator Instructions)
As a reminder, during today's event, we will be making forward-looking statements. These statements reflect PureTech's current expectations regarding future events, including, but not limited to, statements regarding
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |